Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) crossed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $428.75 and traded as low as $420.84. Intuitive Surgical shares last traded at $420.95, with a volume of 2,213,548 shares trading hands.
Key Stories Impacting Intuitive Surgical
Investors following ISRG have been watching these stories:
- Positive Sentiment: BTIG Research raised its price target to $513 from $454 and reiterated a “buy” rating, citing potential upside. BTIG Research rating information
- Positive Sentiment: Recent coverage highlights adjusted EPS growth of 25%, supported by robotic-platform adoption and AI-related innovation. This suggests strong demand and continued earnings growth, though higher R&D costs and a litigation settlement are offsets. ISRG EPS and innovation article
- Neutral Sentiment: EVP Mark Brosius reported sales totaling 92 shares across two transactions, worth about $40,250. Both were made under a pre-arranged Rule 10b5-1 plan, and the small size makes them a limited signal about management’s view of the stock. SEC insider-trading filing
Analyst Ratings Changes
Several equities research analysts recently weighed in on the stock. Leerink Partners set a $503.00 target price on shares of Intuitive Surgical and gave the stock an "outperform" rating in a research note on Wednesday, October 21st. Zacks Research raised shares of Intuitive Surgical from a "hold" rating to a "strong-buy" rating in a research report on Thursday, October 22nd. BMO Capital Markets restated an "outperform" rating on shares of Intuitive Surgical in a research note on Tuesday. Barclays reaffirmed an "overweight" rating and set a $500.00 price objective (up from $485.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Finally, HSBC cut Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price objective on the stock. in a research note on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $495.90.
View Our Latest Research Report on ISRG
Intuitive Surgical Trading Down 2.2%
The firm has a market capitalization of $145.92 billion, a price-to-earnings ratio of 50.90, a price-to-earnings-growth ratio of 2.97 and a beta of 1.45. The stock's fifty day moving average price is $421.98 and its two-hundred day moving average price is $428.75.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts' consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the previous year, the firm posted $2.40 earnings per share. The company's revenue was up 21.7% compared to the same quarter last year. Analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.
Insider Buying and Selling at Intuitive Surgical
In other news, Director Craig H. Barratt sold 1,150 shares of the firm's stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total transaction of $529,000.00. Following the sale, the director owned 1,150 shares of the company's stock, valued at approximately $529,000. This trade represents a 50.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of the business's stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $478,416.40. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 39,394 shares of company stock worth $17,748,935. Corporate insiders own 0.60% of the company's stock.
Institutional Trading of Intuitive Surgical
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. Fi3 FINANCIAL ADVISORS LLC grew its position in shares of Intuitive Surgical by 19.1% in the 3rd quarter. Fi3 FINANCIAL ADVISORS LLC now owns 1,002 shares of the medical equipment provider's stock valued at $407,000 after buying an additional 161 shares during the last quarter. Heartland Bank & Trust Co raised its stake in Intuitive Surgical by 4.7% during the 3rd quarter. Heartland Bank & Trust Co now owns 2,082 shares of the medical equipment provider's stock worth $847,000 after acquiring an additional 94 shares in the last quarter. Harbor Advisors LLC acquired a new stake in Intuitive Surgical during the 3rd quarter worth $203,000. Innovator Capital Management LLC purchased a new stake in Intuitive Surgical in the third quarter valued at $7,982,000. Finally, Brown Financial Advisors lifted its position in Intuitive Surgical by 25.5% in the third quarter. Brown Financial Advisors now owns 2,877 shares of the medical equipment provider's stock valued at $1,170,000 after acquiring an additional 584 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.